Carnitine Prices, Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data Report 2026 Edition
Carnitine Price Trend, Index and Forecast
Track the latest insights on carnitine price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Carnitine Prices Outlook Q1 2026
- USA: USD 25516/MT
- China: USD 23107/MT
- Germany: USD 31956/MT
- India: USD 20792/MT
- United Kingdom: USD 28732/MT
Carnitine Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the first quarter of 2026, the carnitine prices in the USA reached 25516 USD/MT in March. The market experienced a slight upward trend supported by steady demand from the pharmaceutical and nutraceutical sectors. Consumption remained consistent as dietary supplement applications maintained stable growth. Supply conditions remained controlled due to stable production and balanced imports. Market participants followed cautious procurement strategies, ensuring adequate inventory without excess accumulation.
During the first quarter of 2026, the carnitine prices in China reached 23107 USD/MT in March. The market recorded moderate price growth driven by steady domestic demand and export activity. Production levels remained stable, ensuring consistent supply availability. Demand from the pharmaceutical and food supplement industries supported consumption patterns. Export demand contributed to tightening supply conditions in the domestic market. Buyers maintained balanced procurement strategies, avoiding aggressive stocking.
During the first quarter of 2026, the carnitine prices in Germany reached 31956 USD/MT in March. The market observed a slight increase supported by steady demand from health and pharmaceutical sectors. Supply conditions remained balanced due to consistent imports and stable production levels. Consumption from dietary supplement manufacturers remained firm, contributing to stable market activity. Buyers followed cautious procurement practices, maintaining necessary inventory levels.
During the first quarter of 2026, the carnitine prices in India reached 20792 USD/MT in March. The market experienced moderate growth driven by steady demand from the pharmaceutical and nutraceutical industries. Domestic production remained consistent, while import activity ensured sufficient supply. Consumption levels remained stable, supporting ongoing market activity. Buyers maintained cautious procurement strategies, avoiding excessive stock accumulation. Additionally, stable logistics and operational costs contributed to gradual price increases.
During the first quarter of 2026, the carnitine prices in the United Kingdom reached 28732 USD/MT in March. The market recorded a slight increase influenced by stable demand from the dietary supplement and pharmaceutical sectors. Supply conditions remained balanced due to consistent imports and steady production. Consumption patterns remained stable, supporting market stability. Buyers adopted cautious purchasing strategies, maintaining adequate inventory levels.
Carnitine Prices Outlook Q3 2025
- USA: USD 25150/MT
- China: USD 22500/MT
- Germany: USD 32400/MT
- India: USD 20500/MT
- United Kingdom: USD 28800/MT
During the third quarter of 2025, the carnitine prices in the USA reached 25150 USD/MT in September. Prices moved upward as demand from dietary supplements, pharmaceuticals, and functional nutrition products increased. Higher consumption of health and wellness products supported buying interest. Manufacturers secured material to support formulation requirements, while controlled supply availability influenced procurement planning.
During the third quarter of 2025, the carnitine prices in China reached 22500 USD/MT in September. Prices increased due to firm demand from nutraceutical manufacturing and export-oriented supplement production. Improved downstream order volumes supported consumption. Producers maintained structured output levels, while buyers aligned procurement with confirmed manufacturing schedules.
During the third quarter of 2025, the carnitine prices in Germany reached 32400 USD/MT in September. Prices rose as pharmaceutical and medical nutrition demand strengthened. Increased use of carnitine in therapeutic formulations supported consumption. Buyers emphasized quality compliance and regulatory standards, influencing sourcing decisions and procurement timing.
During the third quarter of 2025, the carnitine prices in India reached 20500 USD/MT in September. Prices moved upward amid rising demand from dietary supplement manufacturers and pharmaceutical producers. Expansion in domestic nutraceutical consumption supported offtake. Buyers secured material to support production runs, while import availability influenced sourcing strategies.
During the third quarter of 2025, the carnitine prices in the United Kingdom reached 28800 USD/MT in September. Prices increased as demand from sports nutrition, clinical nutrition, and pharmaceutical applications strengthened. Higher usage in specialty formulations supported procurement activity. Buyers focused on ensuring consistent supply for regulated end-use applications.
Carnitine Prices Outlook Q2 2025
- USA: USD 24090/MT
- China: USD 21410/MT
- Germany: USD 31215/MT
- India: USD 19960/MT
- United Kingdom: USD 27045/MT
During the second quarter of 2025, the carnitine prices in the USA reached 24090 USD/MT in June. Demand from dietary supplements and pharmaceutical applications guided procurement activity. Buyers aligned purchases with production requirements, while supply availability supported routine sourcing.
During the second quarter of 2025, the carnitine prices in China reached 21410 USD/MT in June. Consumption from nutraceutical and export-focused supplement manufacturing influenced buying patterns. Producers operated according to scheduled output, and buyers sourced material based on confirmed orders.
During the second quarter of 2025, the carnitine prices in Germany reached 31215 USD/MT in June. Demand from pharmaceutical and clinical nutrition sectors shaped procurement volumes. Buyers emphasized compliance with quality and regulatory standards, influencing sourcing preferences.
During the second quarter of 2025, the carnitine prices in India reached 19960 USD/MT in June. Domestic supplement manufacturing activity supported demand. Buyers coordinated procurement with production planning, while import flows influenced availability.
During the second quarter of 2025, the carnitine prices in the United Kingdom reached 27045 USD/MT in June. Consumption from sports nutrition and medical nutrition segments influenced procurement. Buyers scheduled sourcing based on formulation requirements and supply planning.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing carnitine prices.
Europe Carnitine Price Trend
Q1 2026:
The carnitine price index in Europe showed a steady upward trend supported by stable demand from the pharmaceutical and nutraceutical industries. Consumption from dietary supplement manufacturers remained consistent, ensuring continuous market activity across major economies. Demand for functional ingredients in health products contributed to sustained offtake, while the pharmaceutical sector maintained regular procurement cycles. Supply conditions remained balanced due to steady imports and stable regional production, preventing any supply disruptions.
Q3 2025:
As per the carnitine price index, Europe experienced upward price movement, reflected by increases in Germany and the United Kingdom. Demand from pharmaceutical manufacturing, clinical nutrition, and regulated dietary supplement production supported consumption across the region. Increased focus on therapeutic and preventive health applications drove usage in specialized formulations. Buyers emphasized supplier qualification, traceability, and compliance with regulatory standards. Procurement strategies were aligned with production planning for high-value formulations rather than volume expansion.
Q2 2025:
In Europe, carnitine demand was shaped by pharmaceutical production schedules and nutraceutical formulation planning. Buyers coordinated procurement with manufacturing timelines and regulatory approval requirements. Consumption patterns reflected steady usage in medical nutrition and supplement applications. Supply availability and established import channels supported sourcing, while procurement decisions prioritized quality consistency and certification standards.
This analysis can be extended to include detailed carnitine price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Carnitine Price Trend
Q1 2026:
The carnitine price index in North America reflected moderate growth driven by steady demand from the health and supplement sectors. Consumption remained consistent as the use of carnitine in dietary and performance nutrition applications supported ongoing market activity. The pharmaceutical sector also contributed to stable demand, ensuring regular procurement. Supply conditions remained controlled due to stable domestic production and balanced import flows, which maintained adequate availability without creating excess supply.
Q3 2025:
As per the carnitine price index, North America experienced upward price movement, reflected by increases in the USA. Demand from sports nutrition, dietary supplements, and pharmaceutical applications strengthened consumption. Increased focus on active lifestyle products and clinical nutrition supported higher usage. Buyers secured material ahead of formulation cycles, while procurement emphasized supplier reliability and compliance with food and drug regulations.
Q2 2025:
In North America, carnitine demand reflected procurement aligned with supplement manufacturing and pharmaceutical production planning. Buyers focused on sourcing volumes matched to operational needs. Consumption was driven by routine production of nutraceutical products, while supply availability supported structured purchasing without encouraging excess inventory build-up.
Specific carnitine historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Carnitine Price Trend
Q1 2026:
The study examines the Middle East and Africa's carnitine trends and pricing chart, taking into account variables that specifically affect market prices, such as regional industrial expansion, the availability of natural resources, and geopolitical tensions.
Q3 2025:
As per carnitine price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the carnitine pricing trends and carnitine price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on carnitine prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East and Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Carnitine Price Trend
Q1 2026:
In the Asia Pacific region, carnitine prices showed moderate growth driven by steady demand from the pharmaceutical and nutraceutical sectors. The region’s strong manufacturing base supported consistent consumption, particularly from dietary supplement and functional food producers. Production levels remained stable across key countries, ensuring adequate supply availability. Export activity contributed to maintaining balanced supply conditions, while domestic demand remained firm. Market participants maintained cautious inventory management practices, ensuring supply continuity without excessive stock accumulation.
Q3 2025:
Asia Pacific experienced upward pricing momentum, reflected by increases in China and India. Expansion in nutraceutical manufacturing and export-oriented supplement production supported higher carnitine consumption. Demand from functional food and dietary supplement sectors influenced procurement volumes. Buyers coordinated sourcing with manufacturing schedules and regulatory compliance requirements.
Q2 2025:
In Asia Pacific, carnitine demand was driven by pharmaceutical and nutraceutical manufacturing activity. Buyers scheduled procurement based on production planning and export commitments. Supply availability supported sourcing across major producing and consuming countries, while procurement decisions emphasized quality assurance.
This carnitine price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Carnitine Price Trend
Q1 2026:
The market for carnitine in Latin America is primarily driven by the region's abundant natural resources, especially in nations like Brazil and Chile. However, the price of carnitine might fluctuate significantly due to political unpredictability and uneven regulatory frameworks.
Q3 2025:
Latin America's carnitine market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in carnitine prices.
Q2 2025:
Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting Latin America’s ability to meet international demand consistently. Moreover, the carnitine price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing carnitine pricing trends in this region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Carnitine Pricing Report, Market Analysis, and News
IMARC's latest publication, “Carnitine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the carnitine market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of carnitine at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed carnitine prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting carnitine pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Carnitine Industry Analysis
The global carnitine industry size reached USD 327.2 Million in 2025. By 2034, IMARC Group expects the market to reach USD 585.4 Million, at a projected CAGR of 6.68% during 2026-2034. Market growth is supported by rising demand for dietary supplements, increasing use of carnitine in pharmaceutical and clinical nutrition applications, growing awareness of metabolic health, and expanding consumption of functional and sports nutrition products globally.
Latest News and Developments:
- March 2026: A recent experimental study highlighted the potential therapeutic benefits of L carnitine in managing polycystic ovary syndrome. Conducted on Wistar rats, the research demonstrated that L carnitine supplementation improved hormone balance, reduced insulin resistance, and enhanced ovarian structure. Treated subjects showed improved follicle development and reduced markers linked to metabolic dysfunction.
- May 2025: A pilot clinical study published in NIH reported that blood and urinary levels of carnitine significantly decreased during oxaliplatin-based chemotherapy infusion, suggesting that increased renal excretion may lead to carnitine deficiency and contribute to chemotherapy-induced peripheral neuropathy (CIPN). The findings highlight the clinical importance of monitoring carnitine status and evaluating targeted carnitine supplementation strategies in patients receiving oxaliplatin treatment.
Product Description
Carnitine, a natural compound occurring in the body of a human being, happens to be synthesized from amino acids, namely, lysine and methionine. It is a part of energy metabolism that helps in the transportation of fatty acids into mitochondria, by which they are oxidized, and further energy is obtained. Moreover, carnitine conducts the task of removing the improper products of metabolism from cells, which consequently leads to better cellular health. Commercially, carnitine is synthesized chemically or extracted from natural sources. Animal tissues, and particularly red meat, are the main sources of carnitine extraction. It can be either from natural sources or synthetic resources to satisfy industrial demand.
Carnitine supplements are very popular for many reasons, including increasing athletic performance, boosting fat burning, leading to weight loss, and relieving angina and peripheral artery disease. The multiple functions of carnitine, such as its usage in the treatment of carnitine deficiency disorders and composition in infant formulas to mimic the nutritional composition of breast milk, are also considered.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Carnitine |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Carnitine Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of carnitine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of FOB and CIF prices.
- The study examines factors affecting carnitine price trend, including input costs, supply-demand shifts, and geopolitical impacts, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The carnitine price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.